Japan's Terumo plans to launch a new type of insulin needle in China in January, taking advantage of the nation's growing number of diabetics
Join thousands of industry professionals who rely on Scrip for daily insights
Already a subscriber?
The drugmaker won US FDA approval for the HIF-2α inhibitor in pheochromocytoma and paraganglioma, a rare cancer of the adrenal glands, in adolescents and adults.
Policy experts and pharma executives react to President Trump’s executive order on “equalizing” drug prices between the US and comparable nations at the ISPOR 2025 conference.
Shares are hit as German conglomerate lowers revenue forecast.
